Gold vs US Dollar

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Spero Therapeutics Inc (SPRO)
Spero Therapeutics Inc (SPRO) Financials

SPRO Spero Therapeutics Inc

1.10

0.02 (1.85%)

03 Jan 2025 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-285.736	-85.961	-37.452	-51.827	-60.319	-55.316	-31.375	14.848
Return on Equity (%)	88.282	-258.181	-41.494	-63.987	-75.774	-81.475	-56.527	24.948
Return on Invested Capital (%)	97.081	-238.097	-43.094	-68.344	-80.094	-84.118	-55.218	36.361
Operating Margin (%)	-9743.582	-2015.462	-1050.479	-335.73	-839.014	-481.025	-81.874	24.478
Net Profit Margin (%)	-8933.731	-2329.308	-1050.479	-335.73	-839.014	-491.652	-86.742	21.975
Book Value Per Share	-147.009	5.913	6.733	3.886	4.512	2.725	1.447	2.017
Earnings Per Share	-89.337	-3.208	-2.421	-3.175	-2.675	-2.77	-0.885	0.43
Cash Per Share	30.791	6.075	1.981	1.549	2.912	3.475	2.08	1.44
Working Capital Per Share	14.788	5.839	6.504	3.582	4.265	4.296	1.752	1.774
Operating Profit Per Share	1	0.138	0.231	0.946	0.319	0.563	1.02	1.958
EBIT Per Share	-97.436	-2.776	-2.421	-3.175	-2.675	-2.77	-0.885	0.479
EBITDA Per Share	-97.436	-2.776	-2.421	-3.175	-2.675	-2.77	-0.885	0.479
Free Cash Flow Per Share	-87.755	-3.231	-2.304	-3.197	-2.696	-2.79	-0.898	0.423

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	335k	14.37M	17.21M	19.19M	29.26M	32.39M	52.46M	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	52.46M	52.57M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-641.179	N/A	N/A	N/A	-136.711	N/A	N/A
Net Profit Margin (%)	N/A	-641.179	N/A	N/A	N/A	-136.711	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	58.88M
Price to Earnings Ratio	2.63
Price to Sales Ratio	0.58
Price to Cash Ratio	0.79
Price to Book Ratio	0.56
Dividend Yield	-

Share Statistics

Shares Outstanding	54.52M
Average Volume (1 week)	251.72k
Average Volume (1 Month)	258.37k
52 Week Change	-26.67%
52 Week High	1.89
52 Week Low	0.9187

More Ratios Coming Soon!

Spero Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions